Clinic de Genolier Genolier
Department of Oncology (205)
Specialized in: oncology
About the department
The Department of Oncology at the Clinic de Genolier Genolier offers the full range of services in the field of prevention, diagnostics and treatment of cancer of various localization. The department is headed by Dr. med. Matti Aapro, a highly competent world-famous specialist.
The department practices the most effective therapeutic methods against cancer, for example, chemotherapy, hormone therapy, radiation therapy, immunotherapy, targeted therapy, and many others. All therapeutic interventions comply with the strict international medical protocols.
The specialists of the department prefer an interdisciplinary approach, therefore, there are regularly held tumor boards with the participation of oncologists, radiologists, internists and other experts. During such tumor boards, the doctors jointly discuss each clinical case and carefully develop the optimal treatment plan for each patient. After the necessary medical procedures, due attention is paid to the follow-up monitoring of the patient in order to avoid cancer recurrence.
The department provides both comprehensive diagnostics and treatment of the following oncological diseases:
- Gastrointestinal cancer (stomach, small and large intestine, pancreas, etc.)
- Brain cancer
- Spinal cord cancer
- Gallbladder cancer
- Endocrine cancer (thyroid, parathyroid, adrenal glands)
- Skin cancer
- Blood cancer (leukemias, lymphomas)
- Bone cancer
- Lung cancer
- Cancer of the female reproductive organs (uterine, cervical, ovarian cancers, etc.)
- Breast cancer
- Cancer of the male reproductive organs (prostate cancer, testicular cancer, etc.)
- Liver cancer
- Kidney cancer
- Rare malignant tumors of various localization
- Other oncological pathologies
Dr. med. Matti Aapro received his medical education at the Faculty of Medicine, University of Geneva, Switzerland. He was a Fellow at the Arizona Cancer Center in Tucson and a Founding Chair of the Department of Radiation Therapy at the European Institute of Oncology in Milan.
Dr. Aapro is presently Member of the Board of Directors of the Genolier Cancer Centre, Genolier, Switzerland. He is also an Executive Board Member of the International Society for Geriatric Oncology (SIOG), one of the Directors of the European School of Oncology (ESO), a Board Member of the European CanCer Organization (ECCO). He used to be a President of the Multinational Association of Supportive Care in Cancer (MASCC), and now he is a Chair of its Antiemetic Study Group (2017 - 2019), and the Honorary President of the French-speaking Association for Supportive Care in Cancer (AFSOS). He was a Board Member of the European Organization for Research and Treatment of Cancer (EORTC) and of the European Society of Medical Oncology (ESMO).
Dr. Aapro chaired the scientific and organizing committees of UICC’s World Cancer Congress of 2008 in Geneva, and 2010 in Shenzhen (China). He is a Member of the ESMO Faculty and chaired the ESMO 2017 Palliative and Supportive Care Track. Dr. Aapro is Member of the Scientific Committee of Advanced Breast Cancer Meeting ABC4 (2017). Dr. Aapro is the Editor-in-Chief of Critical Reviews in Oncology/Hematology, as well as Associate Editor for the Geriatric Section of the Oncologist. He is also a Founding Editor of the Journal of Geriatric Oncology. The doctor is the Editor-in-Chief of qualityoflife.elsevierresource.com. He has prepared more than 250 publications and his major interests are new drug development, breast cancer, cancer in the elderly and supportive care.
Dr. Aapro is Doctor Honoris Causa of the University of Tampere (2013) and an owner of the 2010 Acta Oncologica Award, the 2012 ASCO B.J. Kennedy Prize, as well as the Distinguished Services Award of MASCC (2016).
Department of Oncology.
Clinic de Genolier Genolier:
Request more information now.
We will be happy to answer all your questions.
Thank you for your confidence in the Booking Health portal.
A medical coordinator will contact you within 24 hours and answer all questions that might interest you.
you will receive a reply shortly Home